Katerina Mantzavinou

Katerina Mantzavinou

Katerina is a fourth-year PhD student in the Harvard-MIT Health Sciences and Technology (HST) Program, and a member of the Cima Lab at the Koch Institute. She designs implantable drug delivery devices for intraperitoneal cancer therapy, with a focus on metastatic ovarian cancer. Her project aims to make intraperitoneal cancer therapy more accessible and safe for patients, and easier to administer for health providers.

Katerina is originally from Athens, Greece and came to the US in 2007 to attend Harvard College. Her goal is to be an innovator in cost-effective medical technologies. At MIT, she teaches a course on the design and commercialization of cost-effective prosthetic technologies at the MIT D-Lab, is part of the organizing team for an upcoming workshop entitled ‘Rethinking Global Health at MIT,’ and helps drive sustainable medical innovation with MIT Hacking Medicine and the MGH Consortium for Affordable Medical Technologies.